DERMATITIS – Leaf411

DERMATITIS:

2020
Cannabinoids for the Treatment of Chronic Pruritus: A Review. (USA, abstract, 2020) https://pubmed.ncbi.nlm.nih.gov/31987788/
2019
Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System. (Hungary, full, 2019) https://www.mdpi.com/1420-3049/24/5/918/htm
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. (Spain/ UK, full, 2019) https://www.sciencedirect.com/science/article/pii/S2213231719306470?via%3Dihub
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease. (Italy, full, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0223523418308572?via%3Dihub
Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury. (Italy/ Switzerland, full PDF, 2019) https://air.unimi.it/retrieve/handle/2434/652586/1248835/Phyt%20Res%202019-01-04-19-main%20text.pdf
The potential role of cannabinoids in dermatology. (Australia/ USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31599175/
2018
Understanding Terpenes: Linalool. (news – 2018)
https://cannabisnow.com/understanding-terpenes-linalool/
Can marijuana help eczema? (news – 2018)
https://nationaleczema.org/can-marijuana-help/
‘Breaking Good’: How One Nurse’s CBD Microdosing Experiment Turned Into a Saving
Grace (news/ad–2018) https://www.leafly.com/news/health/sana-sana-wellness-microdosing-cbd-for-skin-care
Cannabinoids in dermatology: a scoping review. (USA, full, 2018) https://escholarship.org/uc/item/7pn8c0sb
Anti-inflammatory properties of cannabidiol, a non-psychotropic cannabinoid, in experimental allergic contact dermatitis. (Italy, full, 2018) https://jpet.aspetjournals.org/content/365/3/652.long
Endocannabinoid tone regulates human sebocyte biology. (Hungary/ Switzerland/ Italy/ Germany, full, 2018) https://www.jidonline.org/article/S0022-202X(18)30147-7/fulltext
Occupational cannabis exposure and allergy risks. (Belgium/ Germany, abstract, 2018) https://oem.bmj.com/content/76/2/78.abstract
Insights into future therapeutics for atopic dermatitis. (USA, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29376435/
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. (Spain/ Italy/ USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303484
Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States. (Canada, abstract, 2018) https://journals.sagepub.com/doi/abs/10.1177/1203475418808761?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cmsa
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases. (USA, abstract, 2018) https://link.springer.com/article/10.1007/s40257-018-0410-5
Ajulemic acid: potential treatment for chronic inflammation. (USA, full, 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.394
2017
Rise of the CANNABIS allergy: 36 million Americans are allergic to marijuana – including other people’s – causing asthma, inflammation and rashes (news–2017) http://www.dailymail.co.uk/health/article-4500844/36-million-Americans-allergic-pot-figures-show.html#ixzz4hN8OZxFr
Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers (news–2017) http://www.news-medical.net/news/20170418/Pharmaceuticals-containing-cannabinoids-may-be-effective-against-skin-diseases-say-researchers.aspx
Topical cannabinoids may help to treat skin diseases (news–2017) http://www.medicalnewstoday.com/articles/316968.php
The Risks and Benefits of Cannabis in the Dermatology Clinic. (Canada, click “addictiondomaincom” for download, 2017) https://addictiondomain.com/wp-content/uploads/2018/09/The-Risks-and-Benefits-of-Cannabis-in-the-Dermatology-Clinic.pdf
Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal? (Hungary, full, 2017) https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(17)30003-8/fulltext
The role of cannabinoids in dermatology. (USA, full PDF, 2017) https://greenwaytherapeutix.com/wp-content/uploads/2019/10/2017-Mounessa-American-Academy-of-Dermatology-The-role-of-cannabinoids-in-dermatology-.pdf
The Endocannabinoid System and Its Role in Eczematous Dermatoses. (USA, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/28098721/
The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice. (Japan, abstract, 2017) https://www.karger.com/Article/Abstract/455916
2016
Marijuana allergy can be triggered by toking (news–2016) https://ca.news.yahoo.com/marijuana-allergy-triggered-toking-050000722.html
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model. (Republic of Korea, full, 2016) https://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes. (Italy/ France, full, 2016) https://www.jimmunol.org/content/197/9/3545.long
Dermatological Aspects of Synthetic Cannabinoid Addiction. (Turkey, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27028361/
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis. (Italy, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0014299916306458
2015
Endocannabinoid signaling at the periphery: 50 years after THC. (Italy/ Israel/ Hungary/ USA/ Qatar/ Canada/ Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420685/
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model. (Republic of Korea, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/26095080/
2010
Hemp Seed Oil for Skin (news–2010) http://www.livestrong.com/article/340189-hemp-seed-oil-for-skin/